Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study.
Daniel J DeSalvoNudrat NoorCicilyn XieSarah D CorathersShideh MajidiRyan J McDonoughSarit PolskyRoberto IzquierdoNicole RiolesTracey D BrownKathryn ObrynbaAlissa J RobertsFrancesco VendrameJanine SanchezOsagie A EbekozienPublished in: Journal of diabetes science and technology (2021)
In this real-world study of patients in the T1DX-QI Collaborative, CGM users had better glycemic control and lower rates of DKA and severe hypoglycemia (SH) events, compared to nonusers; however, there were significant sociodemographic disparities in CGM use. Quality improvement and advocacy measures to promote widespread and equitable CGM uptake have the potential to improve clinical outcomes.
Keyphrases
- glycemic control
- type diabetes
- quality improvement
- blood glucose
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- weight loss
- insulin resistance
- cardiovascular disease
- case report
- prognostic factors
- early onset
- patient safety
- healthcare
- patient reported outcomes
- metabolic syndrome
- adipose tissue
- human health